LivaNova (LIVN) Return on Capital Employed Growth (3y) (2019 - 2026)
LivaNova (LIVN) Return on Capital Employed Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.91 Bn | 193.31 Bn | 7.27 Bn | -236.00 |
| 2 | Stryker | 127.59 Bn | 124.11 Bn | 4.50 Bn | 281.00 |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 145.00 |
| 4 | Boston Scientific | 73.24 Bn | 72.70 Bn | 3.85 Bn | 446.00 |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | -433.00 |
| 6 | Dexcom | 34.38 Bn | 32.44 Bn | 830.00 Mn | 1,627.00 |
| 7 | GE HealthCare Technologies | 33.96 Bn | 31.85 Bn | 2.18 Bn | -62.00 |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | - |
| 9 | Steris | 23.08 Bn | 22.60 Bn | 684.20 Mn | 370.00 |
| 10 | LivaNova | 4.29 Bn | 3.77 Bn | 273.67 Mn | 1,509.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1,509.00 |
| Mar 31, 2026 | 1,517.00 |
| Dec 31, 2025 | 1,516.00 |
| Sep 30, 2025 | 1,469.00 |
| Jun 30, 2025 | 638.00 |
| Mar 31, 2025 | 829.00 |
| Dec 31, 2024 | 613.00 |
| Sep 30, 2024 | 1,702.00 |
| Jun 30, 2024 | 1,576.00 |
| Mar 31, 2024 | 1,100.00 |
| Dec 31, 2023 | 938.00 |
| Sep 30, 2023 | 921.00 |
| Jun 30, 2023 | 106.00 |
| Mar 31, 2023 | 333.00 |
| Dec 31, 2022 | 474.00 |
| Sep 30, 2022 | 1,105.00 |
| Jun 30, 2022 | 2,042.00 |
| Mar 31, 2022 | 1,513.00 |
| Dec 31, 2021 | 1,185.00 |
| Sep 30, 2021 | -1,882.00 |